A cancer gene therapy approach through translational control of a suicide gene
- 27 May 2002
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (6) , 505-512
- https://doi.org/10.1038/sj.cgt.7700469
Abstract
The translation initiation factor eIF4E is elevated in most solid tumors resulting in translation of mRNAs that are normally repressed by their structured 5′ untranslated region. We have introduced a translational repressor element in a vector (BK-UTK) designed to express herpes thymidine kinase (HTK). This and a control vector (BK-TK) were used to treat experimental tumors of a murine breast cancer line. Both vectors were equally effective in reducing subcutaneous tumors and lung metastases following ganciclovir administration. However, the BK-TK vector was found to be highly toxic, resulting in severe weight loss, degeneration of various organs, and early death of mice following systemic vector delivery, whereas the BK-UTK increased mean survival without toxicity.Keywords
This publication has 15 references indexed in Scilit:
- Cancer gene therapy: fringe or cutting edge?Nature Reviews Cancer, 2001
- Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progressionBritish Journal of Cancer, 2000
- Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesisOncogene, 1999
- Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancerCancer Gene Therapy, 1999
- Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancerOncogene, 1997
- Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesisInternational Journal of Cancer, 1996
- The proto‐oncogene/translation factor eIF4E: A survey of its expression in breast carcinomasInternational Journal of Cancer, 1995
- Therapeutic agents for treatment of established metastases and inhibitors of metastatic spreadCurrent Opinion in Oncology, 1992
- Multidrug resistance in human cancerCritical Reviews in Oncology/Hematology, 1992
- Problems Posed for Cancer Treatment by Tumor Cell HeterogeneityPublished by Springer Nature ,1986